A detailed history of California State Teachers Retirement System transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 20,160 shares of JANX stock, worth $967,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,160
Previous 20,738 2.79%
Holding current value
$967,680
Previous $868,000 5.41%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.29 - $50.26 $20,397 - $29,050
-578 Reduced 2.79%
20,160 $915,000
Q2 2024

Aug 14, 2024

BUY
$35.12 - $64.78 $157,162 - $289,890
4,475 Added 27.52%
20,738 $868,000
Q1 2024

May 15, 2024

SELL
$7.93 - $49.75 $7,366 - $46,217
-929 Reduced 5.4%
16,263 $612,000
Q4 2023

Feb 13, 2024

BUY
$5.85 - $11.7 $24,096 - $48,192
4,119 Added 31.51%
17,192 $184,000
Q3 2023

Nov 14, 2023

SELL
$9.56 - $14.0 $17,963 - $26,306
-1,879 Reduced 12.57%
13,073 $131,000
Q2 2023

Aug 21, 2023

SELL
$11.08 - $15.92 $26,359 - $37,873
-2,379 Reduced 13.73%
14,952 $177,000
Q1 2023

May 09, 2023

BUY
$11.25 - $22.21 $117,900 - $232,760
10,480 Added 152.97%
17,331 $209,000
Q4 2022

Feb 14, 2023

BUY
$11.1 - $18.26 $854 - $1,406
77 Added 1.14%
6,851 $90,000
Q3 2022

Nov 18, 2022

SELL
$10.82 - $16.84 $6,102 - $9,497
-564 Reduced 7.69%
6,774 $92,000
Q2 2022

Aug 15, 2022

SELL
$9.52 - $15.65 $2,294 - $3,771
-241 Reduced 3.18%
7,338 $90,000
Q1 2022

May 16, 2022

BUY
$13.24 - $20.24 $5,693 - $8,703
430 Added 6.01%
7,579 $109,000
Q3 2021

Nov 15, 2021

BUY
$20.7 - $34.69 $147,984 - $247,998
7,149 New
7,149 $155,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.